![](https://www.abdn.ac.uk/news/images/thumbs/sugar_brain.jpg)
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit for type 2 diabetes is achieved by acting in our brain.
This article was originally posted by The Rowett Institute